Goncalves Joana — SEC insider filings

SEC reporting owner CIK 1756991. 46 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 46 filings on record, filed 2020-10-22 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oruka Therapeutics, Inc. (ORKA)Chief Medical Officer14—46 legs · 86,535 sh · $5,773,79951
Cara Therapeutics, Inc. (CARA)CHIEF MEDICAL OFFICER32—26 legs · 68,515 sh · $780,61711

Insider filings — Goncalves Joana

FiledFormIssuerReported transactionsSource
2026-11-164Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,600 @ $99.52 · Sale (S): 1,500 @ $100.48 · Sale (S): 1,900 @ $101.53 · Sale (S): 300 @ $102.47 · +4 moreEDGAR
2026-10-154Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,853 @ $73.89 · Sale (S): 1,847 @ $74.69 · Sale (S): 1,400 @ $75.48 · Sale (S): 700 @ $76.67 · +3 moreEDGAR
2026-09-154Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,384 @ $91.10 · Sale (S): 3,150 @ $92.03 · Sale (S): 1,366 @ $92.99 · Sale (S): 100 @ $94.22 · +3 moreEDGAR
2026-08-174Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 900 @ $109.65 · Sale (S): 300 @ $110.52 · Sale (S): 3,320 @ $112.01 · Sale (S): 2,480 @ $112.56 · +2 moreEDGAR
2026-07-154Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 400 @ $84.36 · Sale (S): 2,497 @ $85.86 · Sale (S): 3,803 @ $86.68 · Sale (S): 300 @ $87.25 · +2 moreEDGAR
2026-06-154Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 1,636 @ $68.38 · Sale (S): 5,064 @ $69.42 · Sale (S): 300 @ $70.62 · Sale (S): 947 @ $69.69 · +2 moreEDGAR
2026-05-154Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,800 @ $61.56 · Sale (S): 2,100 @ $62.42 · Sale (S): 100 @ $63.52 · Option exercise (M): 3,500 (derivative) @ $0 · +1 moreEDGAR
2026-04-154Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,227 @ $65.73 · Sale (S): 2,273 @ $66.56 · Sale (S): 500 @ $67.38 · Option exercise (M): 3,500 (derivative) @ $0 · +1 moreEDGAR
2026-03-174Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,921 @ $40.11 · Sale (S): 2,902 @ $41.20 · Sale (S): 1,177 @ $41.94 · Sale (S): 641 @ $41.30 · +2 moreEDGAR
2026-02-174Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 6,064 @ $32.30 · Sale (S): 936 @ $32.78 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 3,500 (derivative) @ $0EDGAR
2026-01-234Oruka Therapeutics, Inc. (ORKA)Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0EDGAR
2026-01-164Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,381 @ $31.56 · Sale (S): 2,619 @ $32.24 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 3,500 (derivative) @ $0EDGAR
2025-12-194Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 641 @ $28.53 · Sale (S): 1,787 @ $29.62 · Sale (S): 1,492 @ $30.70 · Sale (S): 3,080 @ $31.58 · +2 moreEDGAR
2025-01-244Oruka Therapeutics, Inc. (ORKA)Grant/award (A): 162,500 (derivative) @ $0EDGAR
2024-04-094Cara Therapeutics, Inc. (CARA)Sale (S): 2,753 @ $0.83EDGAR
2024-03-044Cara Therapeutics, Inc. (CARA)Sale (S): 3,293 @ $0.89EDGAR
2024-02-124Cara Therapeutics, Inc. (CARA)Sale (S): 7,770 @ $0.53EDGAR
2024-02-054Cara Therapeutics, Inc. (CARA)Grant/award (A): 13,500 @ $0EDGAR
2023-06-274Cara Therapeutics, Inc. (CARA)Sale (S): 2,723 @ $3.51EDGAR
2023-04-064Cara Therapeutics, Inc. (CARA)Sale (S): 2,481 @ $4.91EDGAR
2023-03-074Cara Therapeutics, Inc. (CARA)Sale (S): 6,221 @ $9.71EDGAR
2023-03-034Cara Therapeutics, Inc. (CARA)Grant/award (A): 81,000 (derivative) @ $0EDGAR
2023-02-174Cara Therapeutics, Inc. (CARA)Sale (S): 2,265 @ $10.20EDGAR
2023-01-194Cara Therapeutics, Inc. (CARA)Sale (S): 2,265 @ $10.81EDGAR
2023-01-034Cara Therapeutics, Inc. (CARA)Sale (S): 2,265 @ $10.18EDGAR
2022-12-234Cara Therapeutics, Inc. (CARA)Sale (S): 2,992 @ $11.27EDGAR
2022-04-054Cara Therapeutics, Inc. (CARA)Sale (S): 1,642 @ $11.91EDGAR
2022-03-014Cara Therapeutics, Inc. (CARA)Grant/award (A): 20,000 @ $0 · Sale (S): 1,972 @ $10.29 · Grant/award (A): 80,000 (derivative) @ $0EDGAR
2021-12-214Cara Therapeutics, Inc. (CARA)Grant/award (A): 12,607 @ $0EDGAR
2021-11-034Cara Therapeutics, Inc. (CARA)Sale (S): 1,000 @ $17.15EDGAR
2021-10-284Cara Therapeutics, Inc. (CARA)Sale (S): 1,000 @ $15EDGAR
2021-09-014Cara Therapeutics, Inc. (CARA)Sale (S): 2,110 @ $14.20EDGAR
2021-08-264Cara Therapeutics, Inc. (CARA)Grant/award (A): 6,400 @ $0EDGAR
2021-04-234Cara Therapeutics, Inc. (CARA)Sale (S): 3,000 @ $27.63EDGAR
2021-04-014Cara Therapeutics, Inc. (CARA)Grant/award (A): 16,000 @ $0 · Grant/award (A): 32,000 (derivative) @ $0EDGAR
2021-03-244Cara Therapeutics, Inc. (CARA)Sale (S): 3,000 @ $19.65EDGAR
2021-03-084Cara Therapeutics, Inc. (CARA)Grant/award (A): 10,000 @ $0 · Sale (S): 3,093 @ $17.98EDGAR
2021-02-254Cara Therapeutics, Inc. (CARA)Grant/award (A): 4,000 @ $0 · Sale (S): 3,372 @ $19.33EDGAR
2021-02-244Cara Therapeutics, Inc. (CARA)Sale (S): 2,000 @ $19.73EDGAR
2021-01-254Cara Therapeutics, Inc. (CARA)Sale (S): 2,000 @ $20.12EDGAR
2020-12-304Cara Therapeutics, Inc. (CARA)Sale (S): 1,298 @ $15.30EDGAR
2020-12-294Cara Therapeutics, Inc. (CARA)Grant/award (A): 4,000 @ $0EDGAR
2020-12-234Cara Therapeutics, Inc. (CARA)Sale (S): 2,000 @ $15EDGAR
2020-11-254Cara Therapeutics, Inc. (CARA)Sale (S): 2,000 @ $15.31EDGAR
2020-11-134Cara Therapeutics, Inc. (CARA)Sale (S): 2,000 @ $15EDGAR
2020-10-224Cara Therapeutics, Inc. (CARA)Sale (S): 2,000 @ $15EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1756991 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs